If you are thinking of getting a tattoo, but wonder if it may be one of those things you wish you had of never done. There is good news that was recently released in the medical field about a new tattoo ink.
Freedom-2, LLC, a pioneer in the development of safe, quality inks for the purpose of permanent but removable tattoos today announces their plan to deliver the first inks to the market in early 2007.
The Freedom-2 (F2) ink technology is the first and only patented ink designed specifically for safe and easy, future removal. The technology is the result of combined seminal discoveries by R. Rox Anderson, M.D., Wellman Laboratories of Photomedicine at the Massachusetts General Hospital; Craig A. Drill; Susanna Mlynarczyk-Evans, Ph.D., and Bruce Klitzman, Ph.D. and Kim Edward Koger, M.D., F.A.C.S. of Duke University.
The F2 ink uses biodegradable and bioabsorbable dyes such as cosmetic-grade iron oxide that are encapsulated in a biocompatible polymer bead known as ploymethylmethacrylate (PMMA). These microscopic PMMA beads make up the F2 ink. Tattoo artists use traditional delivery methods to provide an F2 tattoo – the only difference is the ink.
An F2 tattoo is easily removed by a single, standard laser treatment that breaks the PMMA beads allowing the body to naturally expel the dye trapped inside. In contrast, the removal of traditional tattoo inks can create significant side effects including the development of carcinogenic properties, scarring and incomplete removal. Additionally, removing a traditional tattoo typically requires multiple laser treatments that can cost several thousand dollars.
Today approximately 24 percent of Americans have at least one tattoo and as many as 17% of them seek to have their artwork removed1. However, according to prominent physicians and researchers whose practices center around tattoos and tattoo removal, that number may be as high as 50%. Until today, the removal of tattoos delivered with traditional ink, was a painful, incomplete process. With the F2 ink technology, the picture changes.
“The F2 technology was discovered by practicing physicians with experience in the current tattoo removal technology. These doctors, concerned for their patients and future patients, have developed a safe, less expensive, non-invasive system of tattoo removal,” said Martin Schmieg, President and CEO of Freedom-2 LLC. “We are looking forward to presenting this technology to the public and believe it will allow more people to express themselves through body art without future regret.”
The F2 technology is being advanced by a team of researchers led by prominent polymer chemist and drug control delivery systems expert, Edith Mathiowitz, Ph.D at Brown University. Mathiowitz leads the development team and works with research and development partner, MediUm-Tech, GmbH, Berlin, Germany on the encapsulation and formulation of the F2 ink.
Currently, F2 is continuing its human proof of concept studies with testing locations in both the US and Europe. Following a successful suite of product tests, F2 will make the world’s first-ever permanent but removable tattoo ink available for retail sale in early 2007.